Tsfg, LLC Eli Lilly & CO Transaction History

Tsfg, LLC

$458 Million
Q3 2024

A detailed history of Tsfg, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Tsfg, LLC holds 794 shares of LLY stock, worth $630,547. This represents 0.15% of its overall portfolio holdings.

Number of Shares

794

Previous 789 0.63%

Holding current value

$630,547

Previous $714,000 1.54%

% of portfolio

0.15%

Previous 0.17%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$772.14 - $960.02 $3,860 - $4,800	5 Added 0.63%	794 $703,000
Q2 2024 Jul 16, 2024	BUY	$724.87 - $909.04 $2,174 - $2,727	3 Added 0.38%	789 $714,000
Q1 2024 Apr 16, 2024	BUY	$592.2 - $792.28 $20,134 - $26,937	34 Added 4.52%	786 $612,000
Q4 2023 Jan 23, 2024	SELL	$525.19 - $619.13 $3,676 - $4,333	-7 Reduced 0.92%	752 $438,000
Q3 2023 Oct 10, 2023	SELL	$434.7 - $599.3 $32,167 - $44,348	-74 Reduced 8.88%	759 $408,000
Q2 2023 Jul 10, 2023	BUY	$350.74 - $468.98 $350 - $468	1 Added 0.12%	833 $391,000
Q1 2023 Apr 21, 2023	BUY	$310.63 - $364.82 $4,659 - $5,472	15 Added 1.84%	832 $286,000
Q4 2022 Jan 19, 2023	BUY	$321.55 - $374.67 $51,769 - $60,321	161 Added 24.54%	817 $299,000
Q2 2022 Jul 13, 2022	BUY	$278.73 - $327.27 $278 - $327	1 Added 0.15%	656 $213,000
Q4 2021 Feb 10, 2022	SELL	$224.85 - $279.04 $11,917 - $14,789	-53 Reduced 7.49%	655 $181,000
Q3 2021 Oct 12, 2021	SELL	$221.6 - $272.71 $5,983 - $7,363	-27 Reduced 3.67%	708 $164,000
Q2 2021 Jul 19, 2021	BUY	$180.55 - $233.54 $1,263 - $1,634	7 Added 0.96%	735 $169,000
Q1 2021 Apr 14, 2021	SELL	$164.32 - $212.72 $821 - $1,063	-5 Reduced 0.68%	728 $136,000
Q4 2020 Jan 20, 2021	BUY	$130.46 - $172.63 $130 - $172	1 Added 0.14%	733 $124,000
Q3 2020 Oct 06, 2020	SELL	$146.22 - $169.13 $30,559 - $35,348	-209 Reduced 22.21%	732 $108,000
Q2 2020 Jul 07, 2020	BUY	$136.42 - $164.18 $272 - $328	2 Added 0.21%	941 $155,000
Q1 2020 Apr 08, 2020	BUY	$119.05 - $147.35 $357 - $442	3 Added 0.32%	939 $130,000
Q4 2019 Jan 27, 2020	BUY	$106.92 - $132.43 $213 - $264	2 Added 0.21%	936 $123,000
Q3 2019 Jan 27, 2020	BUY	$106.79 - $116.16 $11,212 - $12,196	105 Added 12.67%	934 $104,000
Q2 2019 Jan 27, 2020	BUY	$110.79 - $129.32 $221 - $258	2 Added 0.24%	829 $92,000
Q1 2019 Jan 27, 2020	BUY	$111.31 - $131.02 $92,053 - $108,353	827 New	827 $107,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tsfg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tsfg, LLC with notifications on news.

Account